Početna › Atopijski dermatitis (ekcem) › Missouri
Kliničke studije za Atopijski dermatitis (ekcem) u državi Missouri
7 studija za Atopijski dermatitis (ekcem) traži sudionike na lokacijama u državi Missouri.
Službeni tekst studije (engleski)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Red River Research Partners, Llc- Site Number : 8400054, Bolivar
- Cleaver Dermatology- Site Number : 8400033, Kirksville
U tijeku regrutacijaOpažajna studija
Od 12 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Saint Joseph
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06947993A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Saint Louis University, St Louis
U tijeku regrutacijaFaza 3
Od 2 do 11 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06807281Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- U.S. Dermatology Partners Lee's Summit, Lee's Summit
U tijeku regrutacijaOpažajna studija
Od 12 do 89 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07645820A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Washington University School of Medicine - St. Louis /ID# 268545, St Louis
U tijeku regrutacijaFaza 3
Od 2 do 11 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- MediSearch Clinical Trials /ID# 263579, Saint Joseph
U tijeku regrutacijaFaza 3
Od 18 do 63 godina · Oba spola · Ažurirano 6. srp 2026. · NCT06389136Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7057, Lee's Summit
U tijeku regrutacijaOpažajna studija
Od 12 godina i više · Oba spola · Ažurirano 13. ožu 2026. · NCT06988605Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.